Thomas J. Farrell Named CEO of NanoSyrinx for Biotherapeutics
NanoSyrinx, a synthetic biology company focused on developing Nanosyringes for targeted intracellular delivery of biologic medicines, has named Thomas J. Farrell as Chief Executive Officer and Director. Farrell succeeds...